Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/43071

TitleScreening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies
Author(s)Nóbrega, Franklin Luzia
Ferreira, Débora
Martins, Ivone M.
Maria Suarez-Diez
Azeredo, Joana
Rodrigues, L. R.
Kluskens, Leon
KeywordsClaudin-low breast cancer
Phage display
MDA-MB-231
PRWAVSP
DTFNSFGRVRIE
Issue date24-Oct-2016
PublisherBioMed Central
JournalBMC Cancer
CitationNóbrega, Franklin L.; Ferreira, Débora; Martins, I.; Maria Suarez-Diez; Azeredo, Joana; Rodrigues, Lígia R.; Kluskens, Leon D., Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies. BMC Cancer, 18(881), 1-14, 2016
Abstract(s)Background: Claudin-low breast carcinoma represents 19% of all breast cancer cases and is characterized by an aggressive progression with metastatic nature and high rates of relapse. Due to a lack of known specific molecular biomarkers for this breast cancer subtype, there are no targeted therapies available, which results in the worst prognosis of all breast cancer subtypes. Hence, the identification of novel biomarkers for this type of breast cancer is highly important for early diagnosis and targeted therapy. Methods: In this work, we propose the identification of peptides for the specific recognition of MDA-MB-231, a cell line representative of claudin-low breast cancers, using phage display (both conventional panning and BRASIL). Binding assays were performed to select the most interesting peptides and bioinformatics approaches were applied to putatively identify the biomarkers to which these peptides bind. Results: Two peptides were selected using this methodology specifically targeting MDA-MB-231 cells, as demonstrated by a 4 to 9 log higher affinity as compared to control cells. The use of bioinformatics approaches provided relevant insights into possible cell surface targets for each peptide identified. Conclusions: The peptides herein identified may contribute to an earlier detection of claudin-low breast carcinomas and possibly to develop more individualized therapies.
TypeArticle
URIhttp://hdl.handle.net/1822/43071
DOI10.1186/s12885-016-2937-2
ISSN1471-2407
Peer-Reviewedyes
AccessOpen access
Appears in Collections:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Files in This Item:
File Description SizeFormat 
document_46236_1.pdf1,6 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID